![Peter Selin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Selin
Amministratore Delegato presso KANCERA AB
Profilo
Peter Selin is currently the Chief Executive Officer at Kancera AB.
Previously, he worked as the Chief Business Officer at Vivesto AB and as the Vice President-Pharma Business Operations at Inceptua SA. Mr. Selin completed his undergraduate degree at the University of Uppsala.
Posizioni attive di Peter Selin
Società | Posizione | Inizio |
---|---|---|
KANCERA AB | Amministratore Delegato | 01/07/2023 |
Precedenti posizioni note di Peter Selin
Società | Posizione | Fine |
---|---|---|
VIVESTO AB | Corporate Officer/Principal | - |
Inceptua SA
![]() Inceptua SA Medical/Nursing ServicesHealth Services Inceptua SA is a Luxembourger specialty pharmaceutical company and premium service partner. The company is based in Luxembourg, Luxembourg, and has subsidiaries in the UK. The company commercializes and market orphan and specialty care products, as well as supply unlicensed medicines. Inceptua also provides services such as clinical trial comparator sourcing, packaging and labeling solutions, pre-approval and medicines access programs, and consulting. The company partner with life science companies of all sizes and has over 20 years of industry experience. Inceptua was founded in 1997, and Stefan Fraenkel has been the CEO since 2017. | Corporate Officer/Principal | - |
Formazione di Peter Selin
University of Uppsala | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
VIVESTO AB | Health Technology |
KANCERA AB | Health Technology |
Aziende private | 1 |
---|---|
Inceptua SA
![]() Inceptua SA Medical/Nursing ServicesHealth Services Inceptua SA is a Luxembourger specialty pharmaceutical company and premium service partner. The company is based in Luxembourg, Luxembourg, and has subsidiaries in the UK. The company commercializes and market orphan and specialty care products, as well as supply unlicensed medicines. Inceptua also provides services such as clinical trial comparator sourcing, packaging and labeling solutions, pre-approval and medicines access programs, and consulting. The company partner with life science companies of all sizes and has over 20 years of industry experience. Inceptua was founded in 1997, and Stefan Fraenkel has been the CEO since 2017. | Health Services |
- Borsa valori
- Insiders
- Peter Selin